Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
This demonstrates that FOXO4-DRI selectively targets and eliminates senescent Leydig cells by causing p53 nuclear exclusion and subsequent apoptosis
Public batch ID: GLUT-B003-600MG Archived transparency reports Batch B002 Not Released Archived for transparency Batch B003 will be tested before release Batch B002 was tested by Janoshik and returned a measured content of 622.01 mg with 93.603% purity
Yuniati R et al
You have three administration options: Option A: Injectable GHK-Cu only 200 to 600 mcg per day, subcutaneous Best for systemic tissue support (skin, joints, hair, internal tissues) No fasting required Option B: Topical GHK-Cu only Applied to target areas once or twice daily Best for localized skin concerns (face, abdomen, specific areas of laxity) Lower cost, no injection required Option C: Injectable plus topical (recommended for maximum benefit) Injectable for systemic support plus topical for targeted skin areas Most thorough approach Addresses both internal tissue health and external skin quality Step 4: Improve and Maintain As semaglutide is titrated up over the following months, continue GHK-Cu consistently
You can take it directly from a pouch or mix it into a small amount of water or juice
